MRK

7 Stocks to Buy That Will Grow by Double Digits

Quit trying to time the market and buy these growth stocks that the Street expects to do well regardless of where the overall markets go. More 

BMY Stock: Don’t Try to Catch This Falling Knife … Yet

Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline. More 

Trade of the Day: Buy Merck & Co., Inc. (MRK) … But Not Yet

While Merck looks like it will be rewarding shareholders well in the future, the price of MRK stock is just a little too high right now. More 

This Drug Stock’s Pattern Says, ‘Sell Now!’ (ZTS)

The health care sector has led the market decline over the past few days, and this stock's chart is showing signs of severe weakness... More 

Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full. More 

3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA)

Mylan (MYL) is bouncing back to life on an Epipen settlement, Bristol-Myers Squibb (BMY) is getting hit again on Opdivo disappointment and everyone still hates Comcast (CMCSA). More 

10 Pharmaceuticals Stocks to Buy Now

10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More